Why COVID caused less severe illness in Malawi
Official title: COVID Transmission and Morbidity in Malawi (COVID-TMM)
Funded at Boston University Medical Campus · NIH-11494092 · Data updated 2026-11-12
This project looks at whether past infections like malaria and parasitic worms change adults' immune responses and affect how COVID infections and vaccine protection work in Malawi.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | April 1, 2026 |
| Project end | March 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $105,868 |
| NIH project number | 3R01AI164686-05S1 |
| Project ID | NIH-11494092 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are adults aged 21 and older living in Malawi or similar sub‑Saharan African settings, including people with past or current malaria or parasitic infections and both symptomatic and asymptomatic SARS‑CoV‑2 cases.
✕Less likely to help
People under 21, those not living in sub‑Saharan Africa, or those without a history of malaria or parasitic exposure may not receive direct benefit from the study's findings.
What this research studies
If you join, you would give blood samples and health information so the team can measure antibodies and other immune responses. The researchers will compare people with and without prior malaria or parasitic infections to see how those exposures change innate immunity and antibody responses after infection or vaccination. They'll link those immune measurements to who gets infected, who develops symptoms, and who may spread the virus. The work focuses on adults in Malawi and nearby communities in sub‑Saharan Africa.
Why it matters
Potential benefit: If successful, this work could explain why COVID led to milder illness in parts of sub‑Saharan Africa and help guide better local vaccination and treatment strategies.
How similar studies have gone: Previous research shows malaria and other infections can change innate immunity, but using this explanation for lower COVID severity in sub‑Saharan Africa is relatively new and not yet proven.
Where this research is happening
-
Boston University Medical Campus
Boston, United States Active
Researchers
- Principal investigator: Valim, Clarissa — Boston University Medical Campus
- Study coordinator: Valim, Clarissa
Related research
Other NIH-funded projects on the same topics.
-
Creating a detailed map of early lung cancer changes
This study is looking at early changes in lung tissue that can lead to cancer, specifically focusing on common types of lung cancer, and it's for patients who want to help researchers understand these changes better so they can improve early detection and treatment.
-
Telomere trouble in ALT cancers: what causes damage and how it happens
Researchers are studying why some cancer cells use ALT to lengthen telomeres and how replication stress damages telomeres, aiming to uncover key processes that could be targeted in patients.
-
IL-6 signaling, lung injury, and post-TB lung disease in TB/HIV
This grant tests how a specific immune signal (IL-6) relates to lung damage after tuberculosis in people with and without HIV, aiming to understand who is at risk for lasting lung problems.
-
IL-6 signaling and lung injury after TB and HIV co-infection
This project looks at how a common immune signal called IL-6 relates to lung injury after TB treatment, especially in people who also have HIV.
-
LEAD Africa: advancing Alzheimer’s research across Africa
A new project aims to build Alzheimer’s disease research capabilities in Africa to improve understanding and care for people with dementia.
-
Leading AD and related dementias research in Africa
A multi-country effort aims to build Africa’s capacity to study Alzheimer’s disease and related dementias using scalable, low-cost methods.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.